CVE-2026-123218: IBM Aspera Faspex authorization bypass

CVE-2026-123218 · Severity: critical · CVSS 9.8 · Exploited in the wild · Published 2026-11-07

IBM Aspera Faspex is a secure file transfer and collaboration platform used by enterprises to exchange large files. An authenticated user can craft a malicious message to bypass authorization controls and gain full administrative privileges, allowing complete takeover of the system including access to all transferred files and user accounts.

Technologies: IBM Aspera Faspex. Vendors: IBM.

Quick answers

Is CVE-2026-123218 exploited in the wild?
Yes. CVE-2026-123218 is known to be exploited in the wild, first recorded on 9 November 2026. Treat it as urgent.
How severe is CVE-2026-123218?
Critical severity, with a CVSS score of 9.8, published 7 November 2026.
Which products and versions are affected?
IBM Aspera Faspex 5.0.0 through 5.0.19.
Is there a fix for CVE-2026-123218?
Yes: fixed in 5.0.19 PL1. Junglewise finds every place you run it, drafts the upgrade and applies it once you approve.
How is CVE-2026-123218 attacked?
It is attacked over the network, in a hosted service.
Am I affected by CVE-2026-123218?
Check whether you run IBM Aspera Faspex at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.

How to fix

  • Fixed in: 5.0.19 PL1

Technical details

A privilege escalation vulnerability exists in Faspex 5.0.0 through 5.0.19 where an authenticated attacker can bypass authorization mechanisms via a specially crafted message (CWE-863: Incorrect Authorization). The vulnerability requires an existing user account but allows unauthenticated elevation to administrative privileges over the network. A fix is available in version 5.0.19 PL1.

Affected products

  • IBM Aspera Faspex 5.0.0 through 5.0.19

Timeline

  • 2026-11-07: advisory

References

This page as Markdown. Free to reuse under CC BY 4.0 with a link back.